Please assess the completion status of the following clinical trial:

Trial Title: Long Term Minor Sibling Donor Well-Being

Study Design Characteristics:
- Allocation: None
- Intervention Model: None
- Observational Model: CASE_CONTROL
- Primary Purpose: None
- Time Perspective: PROSPECTIVE
- Masking: None
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~1. sibling of an allogeneic cell therapy transplant patient -- the persons receiving allogeneic transplant may have either an acquired or congenital disease. Acquired diseases include acute lymphoblastic leukemia, acute myelogenous leukemia, severe aplastic anemia, hemoglobinopathies, and lymphomas.Congenital diseases are comprised of hemoglobinopathies and glycogen/lysosomal disorders. Transplant is being considered after failure to respond to traditional therapies or due to the nature of the disease.~2. 5 to 19 years of age~3. speaks English or Spanish~4. one parent or legal guardian willing to participate~5. mentally able to render a valid assessment~6. donor is harvested at this institution~7. donors will participate in the standard psychosocial intervention~8. children in the non-donor group will be matched by age and gender to donor group participants~Exclusion Criteria:~1. participation is limited to one donor per family~2. if a child had matched and declined to donate, that child would not be eligible to participate in the non-donor group

- Gender: ALL
- Minimum Age: 5 Years
- Maximum Age: 19 Years
- Healthy Volunteers: t

Study Arms:
- Anxiety Assessment (Type: None): Minor Donors + Sibling Non-Donors + Parents or Legal Guardians

Based on this trial design, predict the completion outcome and termination type (if applicable).